## **Core Concept**
The question tests knowledge of antiviral drugs, specifically those used to treat hepatitis B and HIV. It requires understanding of the pharmacological properties of various antiviral agents. The correct answer involves identifying a drug with dual efficacy against these two viruses.

## **Why the Correct Answer is Right**
Lamivudine is a nucleoside reverse transcriptase inhibitor (NRTI) that is effective against both hepatitis B virus (HBV) and human immunodeficiency virus (HIV). It works by inhibiting the viral DNA synthesis through its active metabolites, which are incorporated into the viral DNA and cause chain termination. This mechanism is crucial for its effectiveness against both HBV and HIV.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because although some drugs in this class may have activity against one or both of these viruses, the specific correct answer is not listed here.
- **Option B:** This option does not represent a drug known for dual activity against HBV and HIV.
- **Option C:** This option might represent a drug with antiviral properties but is not specifically known for efficacy against both HBV and HIV.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that lamivudine is one of the drugs that can be used in the treatment of both hepatitis B and HIV. Resistance patterns differ between the two viruses, and lamivudine resistance is more commonly seen in HBV. This highlights the importance of combination therapy in HIV treatment and monitoring for resistance in both infections.

## **Correct Answer:** .